Israel’s raises US$60 million, gets FDA ok for urine test

TEL AVIV: Israel's said on Thursday it raised US$60 million in funding and received clearance from the U.S. Food and Drug Administration for its smartphone-based urine albumin test to aid in diagnosing chronic kidney disease.

The funding round was led by Corner Ventures with



participation by Joy Capital Ventures and previous investors Ansonia Holdings, Aleph and Samsung NEXT. The company has raised US$95 million to date.

The funds will be used to accelerate Healthy.ios global expansion and product development.

"The smartphone has the potential to be the great equalizer of healthcare," said Yonatan Adiri, founder and CEO of

This is the company's second FDA clearance. Last year it received clearance for its at-home, smartphone-based urinaly